10.9 %Ten point nine percent of women had infections with multiple HPV strains.
Nigeriainfection à HPVpublished 2026Diagnostic microbiology and infectious diseasePubMeddocument of 21 observations
Gold tier: mechanically validated evidence, with its primary source.
148 evidence items · page 6 / 6
10.9 %Ten point nine percent of women had infections with multiple HPV strains.
Nigeriainfection à HPVpublished 2026Diagnostic microbiology and infectious diseasePubMeddocument of 21 observations
79.1 %79.1% (34/43) of art entries aimed to promote human papillomavirus screening and vaccination.
Nigeriainfection à HPVpublished 2026JMIR formative researchPubMeddocument of 7 observations
54 %Nigeria's HPV vaccination coverage is currently estimated at 54%.
Nigeriainfection à HPVPubMeddocument of 4 observations
10.6 %Only 10.6% of female secondary school students had been vaccinated against HPV.
Nigeriainfection à HPVPubMeddocument of 7 observations
16.6 %The prevalence of oral human papillomavirus (oHPV) among 584 men who have sex with men in Abuja and Lagos, Nigeria, was 16.6%.
Nigeriainfection à HPVobserved 2014 to 2018published 2026International journal of STD & AIDSPubMeddocument of 4 observations
18.5 %18.5% of the respondents reported that their children had been vaccinated against HPV.
Nigeriainfection à HPVpublished 2023African journal of reproductive healthPubMeddocument of 5 observations
56.6 %56.6% of the respondents reported that they will advise their friends to be vaccinated against HPV.
Nigeriainfection à HPVpublished 2023African journal of reproductive healthPubMeddocument of 5 observations
42.3 %42.3% of rural women in North Central Nigeria recognized HPV infection as a risk factor for cervical cancer.
Nigeriacancer du col de l'utérus · infection à HPVpublished 2026Rural and remote healthPubMeddocument of 21 observations
20.65 %The pooled prevalence of cervical HPV in Nigerian women was 20.65%.
Nigeriainfection à HPVpublished 2021Annals of medicinePubMeddocument of 9 observations
1 %HPV vaccine actual uptake remained low at 1% to 15% in most studies conducted in Nigeria.
Nigeriainfection à HPVpublished 2026BMC public healthPubMeddocument of 3 observations
11.3 %In the study, 11.3% of refusals for the HPV vaccine were due to lack of adequate information among students in four secondary schools in Benin City, Nigeria.
Nigeriainfection à HPVpublished 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 10 observations
3 casesThree mothers living with HIV had their daughters vaccinated against HPV.
Nigeriainfection à HPVpublished 2026BMC public healthPubMeddocument of 8 observations
53.7 %Among urban participants in Ibadan, Nigeria, 53.7% preferred HPV self-sampling.
Nigeriainfection à HPVpublished 2026BMJ openPubMeddocument of 11 observations
56.6 %Among peri-urban participants in Ibadan, Nigeria, 56.6% preferred healthcare provider (HCP) sample collection for HPV testing.
Nigeriainfection à HPVpublished 2026BMJ openPubMeddocument of 11 observations
23 %Among 342 men who have sex with men (MSM) in Nigeria, HPV16 prevalence was 23%.
Nigeriainfection à HPVpublished 2020Papillomavirus research (Amsterdam, Netherlands)PubMeddocument of 19 observations
1.4 %HPV awareness among adolescents increased from 1.4% to 19.0% following sensitization.
Nigeriainfection à HPVpublished 2026Journal of the International AIDS SocietyPubMeddocument of 5 observations
2.1 aORLiving with HIV for over 6 years was independently associated with a two-fold increased knowledge about HPV's carcinogenicity (adjusted odds ratio: 2.1, 95% confidence interval: 1.1–4.1).
Nigeriainfection à HPV · VIH/sidapublished 2025Sexual healthPubMeddocument of 9 observations
5 %Human Papillomavirus is responsible for about 5% of the global cancer burden.
Nigeriainfection à HPVpublished 2024Reproductive healthPubMeddocument of 16 observations
HPV was not identified in HIV-positive patients with oropharyngeal carcinomas.
Nigeriainfection à HPV · oropharyngeal carcinomas · VIH/sidapublished 2021The Pan African medical journalPubMeddocument of 4 observations
0.11 aORThe odds of oral HPV and EBV co-infection was lower among males [aOR = 0.11, 95% CI: 0.00–14.51].
Nigeriainfection à HPV · virus Epstein-Barrpublished 2025BMC oral healthPubMeddocument of 4 observations
35.2 %Willingness to receive the HPV vaccine among female secondary school students increased from 35.2% to 79.8% after the intervention.
Nigeriainfection à HPVPubMeddocument of 7 observations
1.9 aORAmong participants in the TRUST/RV368 cohort, recent receptive sex was associated with highly similar anal HPV genotypes at 3 months (adjusted odds ratio 1.9, 95% CI 1.0–3.5).
Nigeriainfection à HPVpublished 2022Sexually transmitted diseasesPubMeddocument of 13 observations
28.1 %28.1% of the participants recognized vaccination as a preventive strategy against HPV infection.
Nigeriainfection à HPVpublished 2024BMC public healthPubMeddocument of 12 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.